NVCR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.95

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

-0.12

EPS Last/This Y

-0.03

EPS This/Next Y

0.43

Price

16.38

Target Price

27.14

Analyst Recom

1.86

Performance Q

-2.61

Upside

-379.7%

Beta

0.99

Ticker: NVCR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	NVCR	16.08	0.12	0.56	21472
2026-07-14	NVCR	15.55	0.12	1.58	21494
2026-07-15	NVCR	16.02	0.12	0.11	21520
2026-07-16	NVCR	16.41	0.12	0.54	21500
2026-07-17	NVCR	15.92	0.12	0.09	21495
2026-07-20	NVCR	15.95	0.06	1.77	16533
2026-07-21	NVCR	15.99	0.06	0.20	16603
2026-07-22	NVCR	15.56	0.06	0.39	16623
2026-07-23	NVCR	19.99	0.07	0.47	16837
2026-07-24	NVCR	17.65	0.10	0.60	18117
2026-07-27	NVCR	17.02	0.09	0.33	18350
2026-07-28	NVCR	16.32	0.09	1.59	18422
2026-07-29	NVCR	15.19	0.10	0.51	18562
2026-07-30	NVCR	15.22	0.10	1.73	18646
2026-07-31	NVCR	14.86	0.09	0.12	18611
2026-08-03	NVCR	15.31	0.09	0.09	18558
2026-08-04	NVCR	16.26	0.09	1.49	18604
2026-08-05	NVCR	16.05	0.09	1.63	18690
2026-08-06	NVCR	15.68	0.10	5.27	18700
2026-08-07	NVCR	16.39	0.10	0.14	18708
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	NVCR	16.09	7.5	70.9	-1.59
2026-07-14	NVCR	15.55	7.5	72.8	-1.59
2026-07-15	NVCR	16.02	7.5	-3.2	-1.59
2026-07-16	NVCR	16.42	7.5	-2.4	-1.59
2026-07-17	NVCR	15.92	7.5	6.8	-1.59
2026-07-20	NVCR	15.95	7.5	1.5	-1.59
2026-07-21	NVCR	15.99	7.5	1.3	-1.59
2026-07-22	NVCR	15.56	7.5	6.3	-1.59
2026-07-23	NVCR	20.00	7.5	-45.3	-1.59
2026-07-24	NVCR	17.64	7.9	20.7	-1.57
2026-07-27	NVCR	17.02	7.9	43.9	-1.57
2026-07-28	NVCR	16.31	23.7	15.8	-1.26
2026-07-29	NVCR	15.19	23.7	19.1	-1.26
2026-07-30	NVCR	15.23	23.7	10.4	-1.26
2026-07-31	NVCR	14.84	23.7	13.8	-1.26
2026-08-03	NVCR	15.31	23.7	6.6	-1.26
2026-08-04	NVCR	15.31	23.7	6.6	-1.26
2026-08-05	NVCR	16.06	25.8	12.3	-1.25
2026-08-06	NVCR	15.67	25.8	13.6	-1.25
2026-08-07	NVCR	16.38	25.8	5.2	-1.25
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	NVCR	-1.75	-0.03	11.42
2026-07-14	NVCR	-1.75	-0.03	11.42
2026-07-15	NVCR	-1.75	-0.03	11.42
2026-07-16	NVCR	-1.75	-0.03	11.42
2026-07-17	NVCR	-1.75	-0.03	11.42
2026-07-20	NVCR	-1.75	0.03	11.42
2026-07-21	NVCR	-1.75	0.03	11.42
2026-07-22	NVCR	-1.75	0.03	11.42
2026-07-23	NVCR	-1.75	0.03	11.42
2026-07-24	NVCR	-1.75	0.03	11.42
2026-07-27	NVCR	-1.74	0.00	10.95
2026-07-28	NVCR	-1.74	0.00	10.95
2026-07-29	NVCR	-1.74	0.00	10.95
2026-07-30	NVCR	-1.74	0.00	10.95
2026-07-31	NVCR	-1.74	0.00	10.95
2026-08-03	NVCR	-1.74	-2.12	10.95
2026-08-04	NVCR	-1.74	-2.12	10.95
2026-08-05	NVCR	-1.74	-2.12	10.95
2026-08-06	NVCR	-1.74	-2.12	10.95
2026-08-07	NVCR	-1.74	-2.12	10.95
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.13

Avg. EPS Est. Current Quarter

-0.24

Avg. EPS Est. Next Quarter

-0.25

Insider Transactions

-1.74

Institutional Transactions

-2.12

Beta

0.99

Average Sales Estimate Current Quarter

182

Average Sales Estimate Next Quarter

185

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

89.2

Max Drawdown 5-Year %

-93.3

Target Price

27.14

P/E

Forward P/E

PEG

P/S

2.73

P/B

5.64

P/Free Cash Flow

EPS

-1.31

Average EPS Est. Cur. Y

-1.25

EPS Next Y. (Est.)

-0.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-21.25

Relative Volume

0.89

Return on Equity vs Sector %

-71.3

Return on Equity vs Industry %

-55.4

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.34

EBIT Estimation

5.2

◆ NVCR Healthcare

$16.39

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

13/25

Volume

7/15

Valuation

10/20

TP/AR

1/10

Options

8/10

RSI

51.2

Range 1M

22.9%

Sup Dist

5.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

20/30

Estimates

1/20

Inst/Vol

1/15

Options

8/10

EPS Yr

-2.5%

EPS NY

34.7%

52W%

56.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +65.6% upside

Quality

6/30

Valuation

14/30

Growth

15/25

Stability

6/10

LT Trend

3/5

Upside

+65.6%

Quality

NVCR — P/E HistoricalMedical Instruments & Supplies

NovoCure Limited

Sector: Healthcare

Industry: Medical Devices

Employees: 1605

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

NVCR

Latest News

—

Caricamento notizie per NVCR…

stock quote shares NVCR – NovoCure Limited Stock Price stock today

news today NVCR – NovoCure Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch NVCR – NovoCure Limited yahoo finance google finance

stock history NVCR – NovoCure Limited invest stock market

stock prices NVCR premarket after hours

ticker NVCR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVCR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y